Skip to main content
OpenTrials
Completed

NCT Number: NCT06648265

EFFECTS OF TRANEXAMIC ACID IN TUMESCENT SOLUTION FOR LIPOSUCTION PROCEDURES

The goal of this trial is to evaluate the effect of adding Tranexamic Acid (TXA) to the tumescent solution used in arm liposuction on postoperative outcomes. Study population includes healthy volunteer adults undergoing Liposculpture procedures. The main question it aims to answer is:

1. Does Tranexamic acid exert benefit on postoperative outcomes after liposuction? Researchers will compare TXA versus traditional tumescent solution to see if there are benefits on adding it to the tumescent solution.

Participants will undergo High Definition Liposculpture involving arms, legs and their torso. One arm will be infiltrated with traditional Klein's tumescent solution and the other one with the same one but adding Tranexamic Acid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liposuction Blood Coagulation Disorders Bruising Contusions Ecchymosis Edema Arm Hematologic Diseases Hematoma Hemic and Lymphatic Diseases Hemorrhage Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms Skin Condition Skin Diseases Skin Manifestations Skin and Connective Tissue Diseases Wounds and Injuries Wounds, Nonpenetrating

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Clinica Dhara

Bogotá, Bogota D.C., 111111, Colombia

About this study

Study Design:

Allocation: Randomized (one arm with TXA, one without) Intervention Model: Crossover assignment (each subject serves as their own control with one arm receiving TXA and the other not) Masking: Double-blind (Participant and Outcomes Assessor)

Interventions:

Experimental Arm (TXA): Infiltration with Klein's tumescent solution (1000 ml of Ringer's Lactate + Epinephrine 1 mg + Lidocaine 1 mg) plus 250 mg of tranexamic acid.

Control Arm: Infiltration with Klein's tumescent solution (1000 ml of Ringer's Lactate + Epinephrine 1 mg + Lidocaine 1 mg) without tranexamic acid.

Recruitment Information:

Adults aged 18-60 undergoing elective High Definition liposuction. No known allergies to TXA or lidocaine. BMI of 30 kg/m^2.

Study Start Date: January 2022. Primary Completion Date: January 2024. Study Completion Date: June 2024. Study Locations: Clinica Dhara, Bogota DC, Colombia.

Data Collection: Photomicrographic analysis with ImageJ (Fiji): Photos taken on days 1, 3, and 7 will be processed to calculate the surface area of ecchymosis.

Manual arm circumference measurements: Measurements will be taken with a tape measure to monitor local swelling/inflammation.

Ethical Considerations:

Informed Consent: Participants will be provided with detailed information about the study and will be required to provide informed consent prior to participation.

IRB Approval: The trial will be conducted in compliance with ethical standards and will be reviewed and approved by an Institutional Review Board (IRB).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18-60 undergoing elective arm liposuction.
  • No known allergies to TXA or lidocaine.
  • BMI < 30.

Exclusion criteria

  • Previous surgery or trauma to the arms.
  • Known coagulation disorders.
  • History of thromboembolic events.
  • ASA > II.

Treatment and study plan

Tranexamic Acid (Topical)

Drug

Add 250 mg of TXA per liter of Klein's Tumescent solution for arm liposculpture

Tumescent solution with dilute lidocaine and epinephrine

Drug

Arm infiltration with traditional Klein's tumescent solution

Primary outcomes

  1. Ecchymosis of the arms

    Time frame: One week

    NAME OF THE MEASUREMENT: Area of ecchymosis of each arm MEASUREMENT TOOL: Photomicrographic analysis with ImageJ (Fiji) Software. UNIT OF MEASURE: Area (in cm^2) affected by bruising normalized to the total area of the arm (in cm^2).

    Timing: Repeated measures in a standard position and lighting conditions after liposuction on days 1, 3 and 7 postoperatively.

Secondary outcomes

  1. Inflammation of the arm

    Time frame: one week

    NAME OF THE MEASUREMENT: Inflammation of the arms MEASUREMENT TOOL: Metric tape to assess the circumference of the arm. UNIT OF MEASURE: Circumference (in cm) measured at the midpoint of the arm. Timing: Repeated measures in a standard position (90 degree elbow flexion and 90 degree shoulder abduction) after liposuction on days 1, 3 and 7 postoperatively.

  2. Satisfaction

    Time frame: 6 months

    NAME OF THE MEASUREMENT: Aesthetic assessment after liposuction.

    MEASUREMENT TOOL: Global Aesthetic Improvement Scale (GAIS), is a standardized scale used primarily in cosmetic and dermatological treatments to assess the overall aesthetic improvement of a patient after a procedure. It consist of three questions:

    • how do you feel about your appearance after surgery? Possible answers: Very much improved, much improved, slightly improved, no change.
    • Are you satisfied with the surgery? Very satisfied, satisfied, not satisfied.
    • Would you recommend the surgical procedure? Possible answers: Yes, perhaps, no.

    UNIT OF MEASURE: Rate of satisfaction, appearance and recommendation of the procedure.

    Timing: Six months after surgery.

Sponsors and collaborators

Lead sponsor

Total Definer Research Group

Other

Registry information

Official study title

IMPACT OF TRANEXAMIC ACID IN TUMESCENT SOLUTION ON POSTOPERATIVE OUTCOMES AFTER LIPOSUCTION: A DOUBLE-BLIND, CONTRALATERAL ARM RANDOMIZED CLINICAL TRIAL

Acronym: ARMTXA

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Oct 18, 2024
Registry last updated
Apr 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.